Equities

Bioporto A/S

Bioporto A/S

Actions
  • Price (EUR)0.237
  • Today's Change-0.002 / -0.84%
  • Shares traded0.00
  • 1 Year change-2.87%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of DKK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments668246
Total Receivables, Net101114
Total Inventory3.792.562.72
Prepaid expenses1.741.561.77
Other current assets, total04.48--
Total current assets8210164
Property, plant & equipment, net2.174.5114
Goodwill, net------
Intangibles, net0.460.771.05
Long term investments2.171.931.74
Note receivable - long term2.73----
Other long term assets------
Total assets9010981
LIABILITIES
Accounts payable6.91104.26
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases2.973.202.98
Other current liabilities, total151718
Total current liabilities253125
Total long term debt4.287.4511
Total debt7.251113
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities303835
SHAREHOLDERS EQUITY
Common stock380335268
Additional paid-in capital------
Retained earnings (accumulated deficit)(320)(264)(222)
Treasury stock - common000
Unrealized gain (loss)------
Other equity, total0.23(0.23)(0.12)
Total equity607046
Total liabilities & shareholders' equity9010981
Total common shares outstanding380348278
Treasury shares - common primary issue0.010.010
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.